Groupe Grimaud, PEN AR LAN Form Genetics Alliance
GLOBAL - Continuing the growth of its international pig genetics business, Groupe Grimaud, parent company of Newsham, has entered into an alliance with PEN AR LAN, an international pig genetics company with operations in France, Poland, Brazil and Canada.
4 April 2011
3 minute read
The
partnership
reinforces
Groupe
Grimaud’s
position
as
a
major
player
in
the
pig
genetics
field,
enhancing
its
operations
in
Europe,
North
America
and
South
America.
Under
the
terms
of
the
agreement,
Groupe
Grimaud’s
pig
division,
Choice
Genetics,
becomes
the
majority
shareholder
of
PEN
AR
LAN.
Newsham
and
PEN
AR
LAN
will
continue
to
operate
as
two
independent
companies
under
Choice
Genetics,
with
each
company
benefitting
from
the
technological
advances
of
the
other.
“I
am
particularly
pleased
with
this
agreement,“
says
Frédéric
Grimaud,
chairman
of
Groupe
Grimaud.
“The
PEN
AR
LAN
management
team
is
in
close
alignment
with
the
vision
of
our
operations
and
is
excited
about
the
future
of
our
business.
This
partnership
is
another
important
step
in
our
ongoing
development
of
the
multi- dspecies
animal
genetics
business.“
PEN
AR
LAN,
with
operations
in
France,
Brazil,
Canada
and
Poland,
disseminates
its
genetics
to
more
than
20
countries
and
continues
to
be
lead
by
CEO
Yves
Naveau.
“Groupe
Grimaud
has
an
undoubted
advantage
in
genomics,
especially
with
the
expertise
of
Newsham
Choice
Genetics,“
Yves
Naveau
says.
“Each
year,
Groupe
Grimaud
reinvests
heavily
in
research
and
development.
With
this
agreement,
it
is
our
objective
to
provide
customers
and
partners
a
complete
range
of
quality
genetic
products
featuring
the
latest
technological
advances.“
Pieter
Seghers,
general
manager
of
Groupe
Grimaud
–
Choice
Genetics,
says
the
alliance
will
provide
the
pig
industry
a
broader
choice
of
genetics
with
proven
performance
in
different
environments.
“Having
the
choice
of
two
genetic
pyramids
based
on
separate
continents
–
America
and
Europe
–
will
allow
us
to
create
new
alliances
in
the
international
market,
utilizing
the
Groupe
Grimaud
global
network,“
Mr Seghers
says.
Newsham
CEO,
Mark
Weaver,
DVM,
concurs.
“Consolidation
creates
opportunities
within
research
and
development
to
increase
our
portfolio
of
lines,
leveraging
the
best
technology
of
both
companies
across
a
larger
scale
and
increasing
the
rate
of
genetic
progress
for
our
customers.“
